Research & Development
Sun Pharma and Moebius Medical's MM-II receives Fast Track designation for osteoarthritis knee pain
6 September 2024 - Indian pharmaceutical company Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) (BSE:524715) and Israel-based Moebius Medical Limited announced on Friday that the US Food and Dr...
Vivet Therapeutics receives Orphan Drug Designation from European Commission for VTX-806
6 September 2024 - Clinical stage biotech company Vivet Therapeutics announced on Thursday that it has received Orphan Drug Designation (ODD) from the European Commission for the company's VTX-80...
SFA Therapeutics names new director of Biostatistics
5 September 2024 - US-based clinical-stage biopharmaceutical company SFA Therapeutics, Inc. announced on Wednesday that it has named Dr Ananda Gubbi, PhD as its new director of Biostatistics.In the ne...
FDA approves Azurity Pharmaceuticals' Nymalize oral solution in 30 mg/5 mL prefilled ENFit syringe
4 September 2024 - US pharmaceutical company Azurity Pharmaceuticals announced on Tuesday that it has received approval from the US Food and Drug Administration (FDA) for its Nymalize (nimodipine) ora...
Innovent's IBI363 receives US FDA Fast Track Designation
4 September 2024 - Chinese biopharmaceutical company Innovent Biologics Inc (HKEX:01801) announced on Tuesday that it has received Fast Track Designation from the US Food and Drug Administration (FDA)...
Roche's PIASKY receives first FDA approval
3 September 2024 - Switzerland-based healthcare company Roche announced on Monday that it has received its first FDA approval for the company's paroxysmal nocturnal haemoglobinuria (PNH) treatmen...